v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities:    
Consolidated net income $ 424.2 $ 418.8
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 281.2 236.4
Stock-based compensation expense 36.7 33.9
Deferred income taxes 26.7 14.1
(Gain) loss on fair market value adjustment and gain on sale of equity investments (2.4) 17.5
Gain on divestiture 0.0 (0.2)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (170.5) (51.3)
Other assets, current and long-term (43.4) 5.3
Current and long term liabilities, excluding debt (475.7) (123.4)
Cash provided by operating activities 76.8 551.1
Investing activities:    
Capital expenditures (315.4) (235.5)
Acquisitions, net of cash acquired (111.4) (861.6)
Cash received from divestiture 98.1 1.5
Cash used in investing activities (328.7) (1,095.6)
Financing activities:    
Net short-term borrowings 386.7 (0.6)
Payments on long-term debt 0.0 (500.1)
Treasury stock purchases 0.0 (69.9)
Dividends paid to Equifax shareholders (95.7) (95.0)
Dividends paid to noncontrolling interests (2.4) (5.8)
Proceeds from exercise of stock options and employee stock purchase plan 8.7 25.1
Payment of taxes related to settlement of equity awards (32.3) (30.4)
Purchase of noncontrolling interests 0.0 (3.6)
Cash provided by (used in) financing activities 265.0 (680.3)
Effect of foreign currency exchange rates on cash and cash equivalents (14.2) (1.7)
Decrease in cash and cash equivalents (1.1) (1,226.5)
Cash and cash equivalents, beginning of period 224.7 1,684.6
Cash and cash equivalents, end of period $ 223.6 $ 458.1

Source